Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996753376> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2996753376 endingPage "14" @default.
- W2996753376 startingPage "1" @default.
- W2996753376 abstract "Aim: A comparative evaluation of the physicochemical and in vitro dissolution properties of metformin hydrochloride tablet brands sampled in five cities in Ghana was undertaken to assess their pharmaceutical equivalence.Place and Duration of Study: Department of Pharmaceutics, KNUST, Kumasi, Ghana, between August 2012 and December 2012Methodology: Fourteen brands of metformin tablets plus the innovator brand, Glucophage, purchased from retail pharmacies were studied. The genuineness of the samples was determined using Fourier transform infra-red (FTIR) spectroscopy and thin layer chromatography (TLC). Pharmacopoeia tests such as uniformity of weight, hardness, friability, disintegration and assay were used to assess the physicochemical equivalence of the tablet brands. In vitro dissolution testing was conducted and the dissolution data subjected to analysis involving dissolution efficiency (DE), similarity factor (f2) and Biopharmaceutics classification system (BCS)-based biowaiver conditions, as a surrogate for bioequivalence studies.Results: All the tablet brands complied with the official specifications for identification, uniformity of weight hardness and disintegration. Brand M9 failed the friability test while brands M5, M9 and M12 failed the assay test. Dissolution efficiency (DE) and similarity factor (f2) of the brands varied with pH of dissolution media with M4 (in 0.1 M HCl) having the highest DE and M9 (in phosphate buffer pH 6.8) the lowest.Conclusion: Eleven of the fifteen tablet brands passed all the official tests and could be regarded as pharmaceutically equivalent but f2 analysis showed only six brands were similar to the reference brand (with f2 values ≥50 in the three dissolution media used). None of the metformin brands satisfied the criteria for BCS-based biowaiver for rapidly dissolving tablets. The study has shown that not all the metformin tablet brands sampled in five cities in Ghana are pharmaceutically equivalent." @default.
- W2996753376 created "2019-12-26" @default.
- W2996753376 creator A5023015927 @default.
- W2996753376 creator A5029464308 @default.
- W2996753376 creator A5032767792 @default.
- W2996753376 creator A5068693780 @default.
- W2996753376 creator A5070752807 @default.
- W2996753376 date "2016-01-10" @default.
- W2996753376 modified "2023-09-24" @default.
- W2996753376 title "Evaluation of the Physicochemical and in vitro Dissolution Properties of Metformin Hydrochloride Tablet Brands Marketed in Five Cities in Ghana" @default.
- W2996753376 doi "https://doi.org/10.9734/bjpr/2016/21862" @default.
- W2996753376 hasPublicationYear "2016" @default.
- W2996753376 type Work @default.
- W2996753376 sameAs 2996753376 @default.
- W2996753376 citedByCount "4" @default.
- W2996753376 countsByYear W29967533762019 @default.
- W2996753376 countsByYear W29967533762022 @default.
- W2996753376 crossrefType "journal-article" @default.
- W2996753376 hasAuthorship W2996753376A5023015927 @default.
- W2996753376 hasAuthorship W2996753376A5029464308 @default.
- W2996753376 hasAuthorship W2996753376A5032767792 @default.
- W2996753376 hasAuthorship W2996753376A5068693780 @default.
- W2996753376 hasAuthorship W2996753376A5070752807 @default.
- W2996753376 hasConcept C134018914 @default.
- W2996753376 hasConcept C178790620 @default.
- W2996753376 hasConcept C185592680 @default.
- W2996753376 hasConcept C2776460385 @default.
- W2996753376 hasConcept C2780323712 @default.
- W2996753376 hasConcept C2909500757 @default.
- W2996753376 hasConcept C43617362 @default.
- W2996753376 hasConcept C555293320 @default.
- W2996753376 hasConcept C556039675 @default.
- W2996753376 hasConcept C71924100 @default.
- W2996753376 hasConcept C88380143 @default.
- W2996753376 hasConceptScore W2996753376C134018914 @default.
- W2996753376 hasConceptScore W2996753376C178790620 @default.
- W2996753376 hasConceptScore W2996753376C185592680 @default.
- W2996753376 hasConceptScore W2996753376C2776460385 @default.
- W2996753376 hasConceptScore W2996753376C2780323712 @default.
- W2996753376 hasConceptScore W2996753376C2909500757 @default.
- W2996753376 hasConceptScore W2996753376C43617362 @default.
- W2996753376 hasConceptScore W2996753376C555293320 @default.
- W2996753376 hasConceptScore W2996753376C556039675 @default.
- W2996753376 hasConceptScore W2996753376C71924100 @default.
- W2996753376 hasConceptScore W2996753376C88380143 @default.
- W2996753376 hasIssue "1" @default.
- W2996753376 hasLocation W29967533761 @default.
- W2996753376 hasOpenAccess W2996753376 @default.
- W2996753376 hasPrimaryLocation W29967533761 @default.
- W2996753376 hasRelatedWork W2365471949 @default.
- W2996753376 hasRelatedWork W2368034700 @default.
- W2996753376 hasRelatedWork W2368330572 @default.
- W2996753376 hasRelatedWork W2369559683 @default.
- W2996753376 hasRelatedWork W2372641446 @default.
- W2996753376 hasRelatedWork W2380703908 @default.
- W2996753376 hasRelatedWork W2388897543 @default.
- W2996753376 hasRelatedWork W2389012658 @default.
- W2996753376 hasRelatedWork W2992873159 @default.
- W2996753376 hasRelatedWork W6509431 @default.
- W2996753376 hasVolume "9" @default.
- W2996753376 isParatext "false" @default.
- W2996753376 isRetracted "false" @default.
- W2996753376 magId "2996753376" @default.
- W2996753376 workType "article" @default.